Shepherd FA - Search Results

1

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials.

Shepherd FA, Fossella FV, Lynch T, Armand JP, Rigas JR, Kris MG. Shepherd FA, et al. Semin Oncol. 2001 Feb;28 Suppl 2:4-9. Semin Oncol. 2001. PMID: 28140080

2

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Leighl NB, Shepherd FA, Kwong R, Burkes RL, Feld R, Goodwin PJ. Leighl NB, et al. Among authors: shepherd fa. J Clin Oncol. 2002 Mar 1;20(5):1344-52. doi: 10.1200/JCO.2002.20.5.1344. J Clin Oncol. 2002. PMID: 11870178

3

Second line chemotherapy for NSCLC: establishing a gold standard.

Fossella FV, Lynch T, Shepherd FA. Fossella FV, et al. Among authors: shepherd fa. Lung Cancer. 2002 Dec;38 Suppl 4:5-12. doi: 10.1016/s0169-5002(02)00167-8. Lung Cancer. 2002. PMID: 12480189 Review.

4

Pemetrexed in the treatment of non-small cell lung cancer.

Shepherd FA. Shepherd FA. Semin Oncol. 2002 Dec;29(6 Suppl 18):43-8. doi: 10.1053/sonc.2002.37470. Semin Oncol. 2002. PMID: 12571810 Review.

5

Surgical treatment of small cell lung cancer.

Szczesny TJ, Szczesna A, Shepherd FA, Ginsberg RJ. Szczesny TJ, et al. Among authors: shepherd fa. Semin Oncol. 2003 Feb;30(1):47-56. doi: 10.1053/sonc.2003.50016. Semin Oncol. 2003. PMID: 12635089 Review.

6

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer.

Sridhar SS, Seymour L, Shepherd FA. Sridhar SS, et al. Among authors: shepherd fa. Lancet Oncol. 2003 Jul;4(7):397-406. doi: 10.1016/s1470-2045(03)01137-9. Lancet Oncol. 2003. PMID: 12850190 Review.

7

Second-line chemotherapy for non-small cell lung cancer.

Shepherd FA. Shepherd FA. Expert Rev Anticancer Ther. 2003 Aug;3(4):435-42. doi: 10.1586/14737140.3.4.435. Expert Rev Anticancer Ther. 2003. PMID: 12934656 Review.

8

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.

Hanna N, Shepherd FA, Fossella FV, Pereira JR, De Marinis F, von Pawel J, Gatzemeier U, Tsao TC, Pless M, Muller T, Lim HL, Desch C, Szondy K, Gervais R, Shaharyar, Manegold C, Paul S, Paoletti P, Einhorn L, Bunn PA Jr. Hanna N, et al. Among authors: shepherd fa. J Clin Oncol. 2004 May 1;22(9):1589-97. doi: 10.1200/JCO.2004.08.163. J Clin Oncol. 2004. PMID: 15117980 Clinical Trial.

9

Current paradigms in first-line treatment of non-small-cell lung cancer.

Shepherd FA. Shepherd FA. Oncology (Williston Park). 2004 Jul;18(8 Suppl 5):13-20. Oncology (Williston Park). 2004. PMID: 15339054 Review.

10

Influence of sex on toxicity and treatment outcome in small-cell lung cancer.

Singh S, Parulekar W, Murray N, Feld R, Evans WK, Tu D, Shepherd FA. Singh S, et al. Among authors: shepherd fa. J Clin Oncol. 2005 Feb 1;23(4):850-6. doi: 10.1200/JCO.2005.03.171. J Clin Oncol. 2005. PMID: 15681530 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

556 results

Search Page

Filters